Lyell Immunopharma
A biotechnology company developing cellular immunotherapies for treating cancer.
2
Funding Rounds
$179.0m
Money raised
Overview
A biotechnology company developing cellular immunotherapies for treating cancer.
-
Website:
- Social accounts:
| Name | Phone | Social networks | |
|---|---|---|---|
| Ri** Kl* | - | - | |
| Ot** Br | - | - | |
| Ha** Bi**** | - | - | - |
| Ca** J. Fr* | - | - | - |
| Wi J. Ri | - | - | - |
| El** Na*** | - | - | |
| Li* Ho**** | - | - | |
| Ro**** Ne**** |
|
- | linkedin twitter facebook |
| Ly** Se*** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Lyell Immunopharma has raised a total of $179m in funding over 2 rounds.
Key Insights:
- Lyell Immunopharma funding round, February 2019: $179m
Lyell Immunopharma funding round, February 2019
$179m
Industries
Lyell Immunopharma is active in the following industries: